|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 16,02 PLN | +6,09% |
|
+6,80% | -40,89% |
| 21/05 | Ryvu Therapeutics : perte nette de 12,6 millions de zlotys au premier trimestre | RE |
| 21/05 | Ryvu Therapeutics S.A. publie ses résultats pour le premier trimestre clos le 31 mars 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +6,09% | +6,80% | +5,67% | -33,80% | -40,89% | -48,16% | -73,03% | -71,39% | -29,49% | 93,57 M | |
| +4,35% | +16,60% | +18,84% | +34,64% | +62,73% | +58,11% | +95,21% | -8,36% | - | 62,53 Md | |
| +2,83% | -3,48% | -9,89% | +10,32% | +4,44% | +24,97% | +67,25% | +186,60% | +5 332,51% | 52,43 Md | |
| +0,91% | -0,83% | -5,50% | -3,48% | -3,17% | -17,01% | -13,43% | -77,24% | - | 23,1 Md | |
| +0,27% | -3,98% | -11,27% | -28,99% | -43,11% | -11,28% | +350,30% | +291,23% | +744,16% | 21,4 Md | |
| +2,86% | +10,16% | +10,16% | +26,26% | +32,44% | +31,69% | -5,04% | -66,28% | - | 21,17 Md | |
| +0,75% | +1,34% | +1,26% | +8,99% | -6,66% | +32,22% | -25,25% | -36,21% | +54,70% | 17,76 Md | |
| +9,88% | +23,61% | +6,16% | +128,88% | +215,08% | +222,87% | +385,49% | +1 576,92% | +781,17% | 15,47 Md | |
| +2,79% | +4,99% | -3,53% | +9,88% | +28,76% | +20,30% | +631,88% | - | - | 14,68 Md | |
| +1,25% | +2,48% | +1,52% | +27,65% | +29,36% | +51,36% | +179,72% | +233,53% | +407,61% | 14,08 Md | |
| -2,99% | +0,80% | +3,48% | +15,99% | +30,91% | +427,69% | +174,60% | +27,71% | +1 350,92% | 12,62 Md | |
| +1,29% | -5,99% | -2,65% | +2,32% | -11,71% | +51,70% | +164,36% | +478,83% | +6 673,65% | 11,73 Md | |
| +0,58% | +3,11% | -5,69% | -28,01% | -14,96% | -43,87% | +192,10% | +106,44% | - | 11,02 Md | |
| -1,67% | +5,70% | -12,26% | -22,86% | -22,64% | -53,55% | +597,42% | +69,12% | +91,94% | 10,98 Md | |
| +0,31% | +0,59% | -8,83% | +2,28% | +24,10% | +118,06% | +137,57% | +160,75% | +550,58% | 10,67 Md | |
| +0,02% | -.--% | +0,19% | +22,16% | +23,23% | +57,67% | +173,58% | +399,03% | - | 9,83 Md | |
| -0,56% | +6,62% | +20,45% | +46,95% | +218,53% | +518,55% | +769,40% | -38,71% | -11,00% | 9,23 Md | |
| +0,17% | +0,14% | +98,91% | +106,13% | +80,45% | +187,28% | +349,20% | +367,97% | - | 8,89 Md | |
| +0,74% | -.--% | -.--% | -.--% | -.--% | -.--% | +100,09% | +69,21% | - | 8,19 Md | |
| -2,67% | +1,20% | -8,54% | -17,76% | +11,60% | +27,74% | +114,27% | -16,48% | - | 7,96 Md | |
| Moyenne | +1,34% | +2,08% | +4,92% | +15,38% | +30,92% | +82,82% | +218,28% | +192,25% | +1 449,70% | 17,19 Md | |
| Moyenne pondérée par Capi. | +1,96% | +3,84% | +3,83% | +18,59% | +32,09% | +68,19% | +179,71% | +170,80% | +2 359,78% |
- Bourse
- Actions
- Action RVU
- Secteur Ryvu Therapeutics S.A.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
